|
?:authorAffiliation
|
-
[\'Department of Infectious Disease, Imperial College London, London, UK.\', \'Division of Infection and Immunity, University College London, London, UK.\', \'Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.\', \'Barts Heart Centre, St Bartholomew\'s Hospital, Barts Health NHS Trust, London, UK.\', \'National Infection Service, Public Health England, Porton Down, UK.\', \'Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.\', \'Viral Pseudotype Unit, Medway School of Pharmacy, Chatham Maritime, Kent, UK.\', \'Department of Infection, Barts Health NHS Trust, London, UK.\', \'Department of Virology, Barts Health NHS Trust, London, UK.\', \'Royal Free London NHS Foundation Trust, London, UK.\', \'William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.\', \'German Heart Centre and Charité University, Berlin, Germany.\', \'Institute of Cardiovascular Science, University College London, UK.\', \'Department of Immunology and Inflammation, Imperial College London, London, UK.\', \'Department of Infectious Disease, Imperial College London, London, UK. r.boyton@imperial.ac.uk.\', \'Lung Division, Royal Brompton & Harefield NHS Foundation Trust, London, UK.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}